Correlation Between Dow Jones and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dow Jones and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dow Jones and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dow Jones Industrial and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Dow Jones and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dow Jones with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dow Jones and Zentalis Pharmaceuticals.
Diversification Opportunities for Dow Jones and Zentalis Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Dow and Zentalis is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Dow Jones Industrial and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Dow Jones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dow Jones Industrial are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Dow Jones i.e., Dow Jones and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dow Jones and Zentalis Pharmaceuticals
Assuming the 90 days trading horizon Dow Jones Industrial is expected to generate 0.12 times more return on investment than Zentalis Pharmaceuticals. However, Dow Jones Industrial is 8.32 times less risky than Zentalis Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.07 per unit of risk. If you would invest 4,257,373 in Dow Jones Industrial on December 30, 2024 and sell it today you would lose (98,983) from holding Dow Jones Industrial or give up 2.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dow Jones Industrial vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
Dow Jones and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Dow Jones Industrial
Pair trading matchups for Dow Jones
Zentalis Pharmaceuticals Llc
Pair trading matchups for Zentalis Pharmaceuticals
Pair Trading with Dow Jones and Zentalis Pharmaceuticals
The main advantage of trading using opposite Dow Jones and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dow Jones position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.Dow Jones vs. Highway Holdings Limited | Dow Jones vs. Companhia Siderurgica Nacional | Dow Jones vs. POSCO Holdings | Dow Jones vs. Grupo Simec SAB |
Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |